scispace - formally typeset
L

Lei Chang

Researcher at Protein Sciences

Publications -  51
Citations -  353

Lei Chang is an academic researcher from Protein Sciences. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 10, co-authored 32 publications receiving 221 citations.

Papers
More filters
Journal ArticleDOI

Using transcriptomics, proteomics and phosphoproteomics as new approach methodology (NAM) to define biological responses for chemical safety assessment.

TL;DR: In this article , the authors examined the cellular responses to two chemicals, caffeine and coumarin, by generating and integrating multi-omic data from multi-dose and multi-time point transcriptomic, proteomic and phosphoproteomic experiments.
Journal ArticleDOI

Open-pFind Verified Four Missing Proteins from Multi-Tissues.

TL;DR: A higher resolution mass spectrometry (MS) interpretation engine might provide an opportunity to identify these buried MPs in complex samples by the combination with multi-tissue large-scale proteomics.
Journal ArticleDOI

Chemically labeled ThUBD permits rapid and super-sensitive imaging of polyubiquitination signals.

TL;DR: It is demonstrated that the previously developed tandem hybrid ubiquitin-binding domain (ThUBD) chemically labeled with a reporter group such as horseradish peroxidase (Thubi-HRP) could significantly improve the robustness and sensitivity of polyubiquitination signal detection.
Posted ContentDOI

The phosphoproteome is a first responder in tiered cellular adaptation to chemical stress followed by proteomics and transcriptomics alteration

TL;DR: Proteomics covering posttranslational modifications can be utilized to provide a more complete coverage of chemical-induced cellular alteration and supplement transcriptomics-based health safety decision making as the cost becomes more affordable.
Journal ArticleDOI

Ac-LysargiNase efficiently helps genome reannotation of Mycolicibacterium smegmatis MC2 155.

TL;DR: Zhang et al. as mentioned in this paper used an in-house developed acetylated LysargiNase to identify peptides other than tryptic peptides, which can identify additional novel peptides for N-terminal correction and ORF identification.